Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-42.14	13.14	22.71
Graham Fair Price	52.66	21444.51	14047.66
PEG	-90.71	0.11	-1.19
Price/Book	0.72	0.73	0.72
Price/Cash Flow	-39.33	17.98	29.64
Prices/Earnings	-55.90	14.42	32.70
Price/Sales	2.07	2.40	2.35
Price/FCF	-39.33	17.98	29.64
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.93	0.68	0.67
Operating Margin	181.27	0.08	0.03
ROA	125.06	< 0.005	< 0.005
ROE	< 0.005	0.01	128.40
ROIC	< 0.005	0.02	661.43
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.08	0.04	95.36
Dividends QOQ	-1.00	-1.00	< 0.005
EBIT QOQ	0.04	1.78	4732.66
EPS QOQ	-0.28	1.31	374.75
FCF QOQ	1.90	0.66	-65.04
Revenue QOQ	0.06	-0.01	-80.56
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	125.29	123.69	-1.28
Days Sales Outstanding (DSO)	32.24	32.43	0.59
Inventory Turnover	0.72	0.73	1.30
Debt/Capitalization	0.10	0.09	-10.71
Quick Ratio	2.62	2.53	-3.51
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	39900.61	40303.32	1.01
Cash	22526.49	24496.24	8.74
Capex	-782.66	-407.65	47.91
Free Cash Flow	969.96	1626.51	67.69
Revenue	12222.39	12182.24	-0.33
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.21	3.10	-3.46
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.70	-3.70	-36.78
Naive Interpretation	Member

06 - Financial Health · Bad

Rating